SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-06-000788
Filing Date
2006-08-09
Accepted
2006-08-09 16:05:08
Documents
6
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a22863e10vq.htm 10-Q 570861
2 EXHIBIT 10.293 a22863exv10w293.htm EX-10.293 13663
3 EXHIBIT 31.1 a22863exv31w1.htm EX-31.1 6835
4 EXHIBIT 31.2 a22863exv31w2.htm EX-31.2 6840
5 EXHIBIT 32.1 a22863exv32w1.htm EX-32.1 3566
6 EXHIBIT 32.2 a22863exv32w2.htm EX-32.2 3571
  Complete submission text file 0000936392-06-000788.txt   606748
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20720 | Film No.: 061017615
SIC: 2834 Pharmaceutical Preparations